使用人工智能和化学信息学开发药物发现平台
Kentaro Kawai1, Yukiko Karuo1, Atsushi Tarui1
1Faculty of Pharmaceutical Sciences, Setsunan University.
Chemical & pharmaceutical bulletin
|September 1, 2024
概括
人工智能 (AI) 和机器学习加速了小分子药物发现. 这些技术有助于分子设计,预测化合物活性,以及了解目标分子的结合姿势.
科学领域:
- 计算化学是一种计算化学.
- 药品化学 药品化学 是一个
- 药物发现 药物发现
背景情况:
- 人工智能 (AI) 已经取得了显著的进步,影响了各种科学领域.
- 机器学习模型越来越多地应用于制药研究.
- 人工智能为药物发现提供各种工具,从数据分析到预测建模.
研究的目的:
- 审查人工智能在小分子药物发现中的应用.
- 要突出AI在分子设计,活动预测和结合姿势预测中的作用.
- 讨论AI在学术药物发现设置中的实用性.
主要方法:
- 在药物发现中对AI应用的文献综述.
- 专注于用于小分子设计和预测的机器学习技术.
- 对人工智能对理解化合物-目标相互作用的贡献进行分析.
主要成果:
- 人工智能模型在设计新型小分子方面取得了重大进展.
- 机器学习准确地预测了潜在药物化合物的生物活性.
- 人工智能有效地预测化合物与向蛋白质的结合姿势.
结论:
- 人工智能,特别是机器学习,是一种强大的工具,可以彻底改变小分子药物发现.
- 人工智能应用程序简化了分子设计,活动和绑定预测.
- 人工智能在学术研究中的整合加快了药物发现管道.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K


